BMC Cancer · 2020 · 19 citations · 28 references
MedicineCancer BiologyOncologyCarcinogenesisMolecular OncologyTumor MicroenvironmentCancer BiomarkersCancer Cell SignalingCancer Molecular PathologyCancer ProgressionImmuno-oncology BiomarkersMolecular Tumor ProfilingDisease-free Survival AssessmentImmune Cell Infiltration DensityImmune InfiltratesImmune MarkersLung AdenocarcinomaLung Squamous Cell CarcinomaTumor Immune Cell InfiltrationTumor Purity Estimation
Abstract Background Sphingosine-1-phosphate receptor ( S1PR1 ) is involved in vascular development, a key process in tumorigenesis. This study aimed to evaluate its roles in tumor development and prognosis. Methods S1PR1 expression levels were analyzed using TIMER and Oncomine database, and the prognostic significance of S1PR1 was assessed using PrognoScan and Kaplan-Meier plotter databases. The relationship between S1PR1 and tumor-infiltrated immune cells was analyzed using TIMER. Results S1PR1 expression was remarkably lower in breast and lung cancer tissues than in the corresponding normal tissues. Lower expression was related to poor overall survival and disease-free survival in breast invasive carcinoma (BRCA), lung adenocarcinoma (LUAD), and lung squamous cell carcinoma (LUSC). A functional network analysis confirmed the function of S1PR1 in regulating vasculogenesis. In addition, S1PR1 levels were significantly negative with regard to the tumor purity of BRCA ( r = − 0.508, P = 1.76e-66), LUAD ( r = − 0.353, P = 6.05e-16), and LUSC ( r = − 0.402, P = − 5.20e-20). Furthermore, S1PR1 levels were significantly positive with regard to infiltrating CD8 + ( r = 0.38, P = 5.91e-35) and CD4 + T cells ( r = 0.335, P = 1.03e-26), macrophages ( r = 0.219, P = 3.67e-12), neutrophils ( r = 0.168, P = 2.03e-7), and dendritic cells (DCs) ( r = 0.208, P = 9.14e-11) in BRCA; S1PR1 levels were significantly positive with regard to CD8 + T cells ( r = 0.308, P = 3.61e-12), macrophages ( r = 0.376, P = 1.01e-17), neutrophils ( r = 0.246, P = 4.15e-8), and DCs ( r = 0.207, P = 4.16e-6) in LUAD; and positive with regard to B cells ( r = 0.356, P = 1.57e-15), CD8 + ( r = 0.459, P = 3.83e-26) and CD4 + T cells ( r = 0.338, P = 3.98e-14), macrophages ( r = 0.566, P = 2.61e-45), neutrophils ( r = 0.453, P = 1.79e-25), and DCs ( r = 0.56, P = 2.12e-40) in LUSC. Conclusions S1PR1 levels are positively correlated with multiple immune markers in breast and lung cancer. These observed correlations between S1PR1 and the prognosis and immune cell infiltration provide a foundation for further research on its immunomodulatory role in cancer.
28
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao, Bülent Arman Aksoy, Uğur Doğrusöz et al. · Science Signaling · 2013 · 15.9K citations · Full text
Medicine, Bioinformatics, Oncology +17
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martínez et al. · Nature Communications · 2013 · 10.7K citations · Full text
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang, Chenwei Li, Chenwei Li et al. · Nucleic Acids Research · 2017 · 10.6K citations · Full text
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li, Jing‐Yu Fan, Binbin Wang et al. · Cancer Research · 2017 · 6.6K citations · Full text
Life Sciences, Immunology, Oncology +17